MMSI Merit Medical Systems Inc.

Fred Lampropoulos Receives Manufacturing Leader of the Year Award from the Utah Manufacturers Association 

Fred Lampropoulos Receives Manufacturing Leader of the Year Award from the Utah Manufacturers Association 

SOUTH JORDAN, Utah, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced that Fred Lampropoulos, Merit’s Chairman and CEO, received the 2022 Manufacturing Leader of the Year Award in the large manufacturing category from the Utah Manufacturers Association. The award honors excellence and tremendous efforts made by outstanding leaders and companies in the state of Utah. Mr. Lampropoulos accepted the award at a ceremony held at The Little America Hotel in Salt Lake City, UT.

Mr. Lampropoulos founded Merit over thirty years ago, and the company has become a leader in the manufacturing industry, designing and manufacturing lifesaving medical devices in Utah ever since. As Merit grew, its manufacturing footprint expanded to include facilities around the globe. Operational excellence is essential to Merit’s success. Each of its manufacturing facilities maintains one or more ISO certifications—international gold standards agreed upon by industry experts—in the areas of environment, energy, and occupational health and safety management. This design and manufacturing strategy has helped Merit grow to become one of the largest companies in Utah, broadening its global presence and helping it reach more than $1 billion in revenue. 

“This award acknowledges Fred’s significant leadership in our industry,” said Todd Bingham, President, and CEO of the Utah Manufacturers Association. “He is a pillar of the community and sets an example that many organizations look up to.”

Upon receiving the award, Mr. Lampropoulos said, “I am honored to accept this award on behalf of the entire Merit family. This award recognizes their hard work and dedication.” He added, “Receiving this award is especially meaningful, as it has been a challenging year for manufacturers. We have faced supply chain interruptions, which only spurred us to find innovative ways to produce more of our own materials. By pivoting distribution efforts, we continued to deliver products to our customers, providing them with the solutions they need to care for their patients.”

ABOUT MERIT MEDICAL  

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 600 individuals. Merit employs approximately 6,800 people worldwide.

TRADEMARKS  

Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc. and its subsidiaries in the United States and other jurisdictions.  

  

CONTACTS  

PR/Media Inquiries  

Sarah Comstock 

Merit Medical  

|  

  

Investor Inquiries  

Mike Piccinino, CFA, IRC  

Westwicke - ICR  

|   



EN
22/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Merit Medical Systems Inc.

 PRESS RELEASE

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer ...

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion SOUTH JORDAN, Utah, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the US commercial release of the Prelude Wave™ Hydrophilic Sheath Introducer with SnapFix™ Securement Technology. The Prelude Wave is the latest innovation in Meri...

 PRESS RELEASE

Merit Medical Reports Second Quarter 2025 Results and Updates Full-Yea...

Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance Highlights† Reported revenue of $382.5 million, up 13.2%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 6.7%, respectivelyGAAP operating margin of 12.3%, compared to 13.6% in prior year periodNon-GAAP operating margin* of 21.2%, compared to 20.1% in prior year periodGAAP EPS $0.54, down 11.6%Non-GAAP EPS* $1.01, up 9.8%Free cash flow* generation of $89.1 million over first six months of 2025, up 8.1% year-over-yearAcquired Biolife Delaware, L.L.C. (“Biolife”), a manufacturer ...

 PRESS RELEASE

Merit Medical Names Martha Aronson as New President and Chief Executiv...

Merit Medical Names Martha Aronson as New President and Chief Executive Officer Fred Lampropoulos will continue to serve as Chairman of Merit’s Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment of Martha Aronson as Merit’s new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will remain as Chairman of the Board, President and CEO ...

 PRESS RELEASE

Merit Medical Systems To Announce Second Quarter 2025 Results On July ...

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025 SOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2025, after the close of the stock market on Wednesday, July 30, 2025. Merit plans to hold its investor conference call on the same day (Wednesday, July 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). To access ...

Merit Medical Systems Inc: 1 director

A director at Merit Medical Systems Inc sold 10,000 shares at 95.190USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch